Log in to save to my catalogue

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infectio...

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infectio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2513690248

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

About this item

Full title

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

Publisher

United States: Public Library of Science

Journal title

PLoS pathogens, 2021-03, Vol.17 (3), p.e1009363-e1009363

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to prevent HIV-1 infection. Subsequent analyses identified antibody and cellular immune responses as correlates of risk (CoRs) for HIV infection. Early predictors of these CoRs could provide insight into vaccine-induced protection and guide efforts to enhanc...

Alternative Titles

Full title

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2513690248

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2513690248

Other Identifiers

ISSN

1553-7374,1553-7366

E-ISSN

1553-7374

DOI

10.1371/journal.ppat.1009363

How to access this item